EverSource Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Sell |
421
-122
| -22% | -$64K | 0.01% | 813 |
|
|
2025
Q1 | $344K | Buy |
543
+73
| +16% | +$46.3K | 0.02% | 478 |
|
|
2024
Q4 | $335K | Sell |
470
-160
| -25% | -$114K | 0.02% | 478 |
|
|
2024
Q3 | $662K | Sell |
630
-5
| -0.8% | -$5.26K | 0.04% | 284 |
|
|
2024
Q2 | $685K | Buy |
635
+119
| +23% | +$128K | 0.05% | 267 |
|
|
2024
Q1 | $460K | Sell |
516
-9
| -2% | -$8.02K | 0.04% | 280 |
|
|
2023
Q4 | $461K | Sell |
525
-39
| -7% | -$34.3K | 0.04% | 258 |
|
|
2023
Q3 | $464K | Buy |
564
+83
| +17% | +$68.3K | 0.05% | 238 |
|
|
2023
Q2 | $346K | Buy |
481
+62
| +15% | +$44.5K | 0.04% | 284 |
|
|
2023
Q1 | $344K | Sell |
419
-4
| -0.9% | -$3.29K | 0.04% | 277 |
|
|
2022
Q4 | $305K | Buy |
423
+156
| +58% | +$113K | 0.05% | 277 |
|
|
2022
Q3 | $185K | Sell |
267
-22
| -8% | -$15.2K | 0.04% | 309 |
|
|
2022
Q2 | $172K | Buy |
289
+122
| +73% | +$72.6K | 0.04% | 276 |
|
|
2022
Q1 | $117K | Buy |
167
+15
| +10% | +$10.5K | 0.03% | 311 |
|
|
2021
Q4 | $96K | Buy |
+152
| New | +$96K | 0.03% | 312 |
|